A newly filed Periodic Transaction Report shows Rep. April McClain Delaney disclosed a sale of Labcorp Holdings Inc. common stock (NYSE: LH), made on behalf of one of her dependent children. The transaction, dated August 25, 2026, falls in the disclosed value range of $100,001 to $250,000, according to the filing submitted to the U.S. House of Representatives under the STOCK Act.
The STOCK Act requires members of Congress and their immediate family, including dependent children, to publicly report securities transactions above certain thresholds within a set window of time. These filings are disclosure requirements, not indications of wrongdoing, and this report does not suggest any illegal activity took place. whoisbuyingnow.com tracks these filings as part of routine monitoring of congressional trading activity.
A Notable Cross-Signal in the Same Window
What makes this filing worth flagging is its timing relative to activity from inside Labcorp itself. Company insider Kerrii B. Anderson also sold shares of LH on August 17, 2026, in a transaction valued at $954,060, according to separate insider filings. That sale occurred just eight days before the transaction date listed in the Delaney family’s report, placing both sales within the same 30-day window.
Insider sales by corporate executives and sales by congressional family members are governed by entirely different disclosure regimes, and there is no evidence linking the two transactions or suggesting coordination between them. Still, when a company insider and a member of Congress’ household both report sales of the same stock in close proximity, it is the kind of pattern that warrants a closer look, if only because it shows up simultaneously across two separate public reporting systems: SEC insider filings and House STOCK Act disclosures.
Labcorp Holdings is a major clinical laboratory and drug development services company, and its stock activity is closely watched given its position in the healthcare and diagnostics sector. Any given sale, whether by a corporate insider or a lawmaker’s family member, can stem from a wide range of personal financial reasons unrelated to the company’s outlook, including portfolio rebalancing, tax planning, or liquidity needs.
Readers should note that the amount range disclosed in STOCK Act filings is a legal requirement, not a precise figure, reflecting bands set by law rather than exact transaction values. As with all congressional disclosures, this report offers a partial window into household financial activity rather than a complete financial picture, and no further details about the reasoning behind the sale are available in the public filing.